224 related articles for article (PubMed ID: 20415226)
1. [Overview of the RAAS in renal damage and hypertension].
Yamamoto T; Nishiyama A
Nihon Jinzo Gakkai Shi; 2010; 52(2):87-91. PubMed ID: 20415226
[No Abstract] [Full Text] [Related]
2. [The renin-angiotensin system in hypertension and in cardiovascular and renal diseases: highlights of the World Congress of Nephrology 2009]].
Romet M
Nephrol Ther; 2010 Jan; 6 Spec No 1():H10-3. PubMed ID: 20129455
[No Abstract] [Full Text] [Related]
3. Direct renin inhibition: an analysis of possible benefits.
Dockery BK; Bisognano JD
Curr Hypertens Rep; 2008 Aug; 10(4):313-8. PubMed ID: 18625162
[TBL] [Abstract][Full Text] [Related]
4. [How I treat... by optimizing the blockade of the renin-angiotensin-aldosterone system].
Schleich F; Krzesinski JM; Piérard L; Scheen AJ
Rev Med Liege; 2008 Apr; 63(4):174-81. PubMed ID: 18575070
[TBL] [Abstract][Full Text] [Related]
5. Novel drugs targeting hypertension: renin inhibitors.
Danser AH
J Cardiovasc Pharmacol; 2007 Aug; 50(2):105-11. PubMed ID: 17703126
[TBL] [Abstract][Full Text] [Related]
6. [Renin inhibition and the kidney].
Ecder T
Turk Kardiyol Dern Ars; 2009 Oct; 37 Suppl 7():28-31. PubMed ID: 20019474
[TBL] [Abstract][Full Text] [Related]
7. Renin-angiotensin system blocking drugs.
Robles NR; Cerezo I; Hernandez-Gallego R
J Cardiovasc Pharmacol Ther; 2014 Jan; 19(1):14-33. PubMed ID: 24038019
[TBL] [Abstract][Full Text] [Related]
8. Effects of Direct Renin Blockade on Renal & Systemic Hemodynamics and on RAAS Activity, in Weight Excess and Hypertension: A Randomized Clinical Trial.
Kwakernaak AJ; Roksnoer LC; Lambers Heerspink HJ; van den Berg-Garrelds I; Lochorn GA; van Embden Andres JH; Klijn MA; Kobori H; Danser AH; Laverman GD; Navis GJ
PLoS One; 2017; 12(1):e0169258. PubMed ID: 28118402
[TBL] [Abstract][Full Text] [Related]
9. The renin inhibitor aliskiren as novel treatment for cardiovascular disease.
Saez AO; Philipp T; Nürnberger J
Recent Pat Cardiovasc Drug Discov; 2006 Nov; 1(3):233-40. PubMed ID: 18221088
[TBL] [Abstract][Full Text] [Related]
10. Aliskiren: a new inhibitor of renin-angiotensin aldosterone system activity.
Dalla Vestra M; Simioni N; Masiero A
Minerva Endocrinol; 2009 Dec; 34(4):333-8. PubMed ID: 20046162
[TBL] [Abstract][Full Text] [Related]
11. Direct renin inhibitors: ONTARGET for success?
Pasha Y; Gusbeth-Tatomir P; Covic A; Goldsmith D
Int Urol Nephrol; 2009; 41(2):341-55. PubMed ID: 19296235
[TBL] [Abstract][Full Text] [Related]
12. Renin-angiotensin system dual blockade using angiotensin receptor plus aliskiren decreases severe proteinuria in kidney transplant recipients.
López V; Martin M; Cobelo C; Aranda P; Cabello M; Sola E; Gutierrez C; Burgos D; Martínez D; Hernandez D
Transplant Proc; 2010 Oct; 42(8):2883-5. PubMed ID: 20970559
[TBL] [Abstract][Full Text] [Related]
13. Rational of the use of aliskiren in hypertension and beyond.
Westermann D; Savvatis K; Schultheiss HP; Tschöpe C
Minerva Cardioangiol; 2009 Dec; 57(6):761-72. PubMed ID: 20019651
[TBL] [Abstract][Full Text] [Related]
14. Cardiovascular and renal pathologic implications of prorenin, renin, and the (pro)renin receptor: promising young players from the old renin-angiotensin-aldosterone system.
Balakumar P; Jagadeesh G
J Cardiovasc Pharmacol; 2010 Nov; 56(5):570-9. PubMed ID: 21108514
[TBL] [Abstract][Full Text] [Related]
15. [The future of renin inhibition].
Uresin AY; Baran E
Turk Kardiyol Dern Ars; 2009 Oct; 37 Suppl 7():32-8. PubMed ID: 20019475
[TBL] [Abstract][Full Text] [Related]
16. Renin inhibitors: novel agents for renoprotection or a better angiotensin receptor blocker for blood pressure lowering?
Pimenta E; Oparil S
Cardiol Clin; 2008 Nov; 26(4):527-35. PubMed ID: 18929229
[TBL] [Abstract][Full Text] [Related]
17. Comparative effects of different modes of renin angiotensin system inhibition on hypercholesterolaemia-induced atherosclerosis.
Lu H; Balakrishnan A; Howatt DA; Wu C; Charnigo R; Liau G; Cassis LA; Daugherty A
Br J Pharmacol; 2012 Mar; 165(6):2000-2008. PubMed ID: 22014125
[TBL] [Abstract][Full Text] [Related]
18. Recent changes in the landscape of combination RAS blockade.
Epstein BJ; Smith SM; Choksi R
Expert Rev Cardiovasc Ther; 2009 Nov; 7(11):1373-84. PubMed ID: 19900020
[TBL] [Abstract][Full Text] [Related]
19. Renin inhibition with aliskiren: where are we now, and where are we going?
Azizi M; Webb R; Nussberger J; Hollenberg NK
J Hypertens; 2006 Feb; 24(2):243-56. PubMed ID: 16508564
[TBL] [Abstract][Full Text] [Related]
20. Have the renin-angiotensin-aldosterone system perturbations in cardiovascular disease been exhausted?
Mansur SJ; Hage FG; Oparil S
Curr Cardiol Rep; 2010 Nov; 12(6):450-63. PubMed ID: 20827517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]